Silvio E. Inzucchi
Yale New Haven Hospital(US)Yale University(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes(2015)11,755 cited
- → Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction(2019)6,600 cited
- → Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes(2016)3,564 cited
- → Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach(2012)3,208 cited
- → Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes(2014)3,061 cited
- → Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction(2022)2,473 cited
- → American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control